Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lior Gepstein

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Methods in Enzymology|December 31, 2003
Development of cardiomyocytes from human ES cellsIzhak Kehat, Michal Amit, Amira Gepstein, et al.
Heart Rhythm|October 19, 2010
A combined gene and cell therapy approach for restoration of conductionAnat Hofshi, Ilanit Itzhaki, Amira Gepstein, et al.
Circulation. Cardiovascular Genetics|November 9, 2013
Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cellsOren Caspi, Irit Huber, Amira Gepstein, et al.
Tissue Engineering. Part A|August 1, 2009
Transplantation of a tissue-engineered human vascularized cardiac muscleAyelet Lesman, Manhal Habib, Oren Caspi, et al.
Heart Rhythm|August 20, 2013
Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardiaAsaad Khoury, Ibrahim Marai, Mahmoud Suleiman, et al.
American Journal of Cardiovascular Disease|March 18, 2024
The role of early cardiac resynchronization therapy implantation in dilated cardiomyopathy patients with narrow QRS carrying lamin A/C mutationMiry Blich, Wisam Darawsha, Allon Eyal, et al.
The American Journal of Cardiology|April 7, 2012
Importance of ventricular tachycardia storms not terminated by implantable cardioverter defibrillators shocks in patients with CASQ2 associated catecholaminergic polymorphic ventricular tachycardiaIbrahim Marai, Asaad Khoury, Mahmoud Suleiman, et al.
Pacing and Clinical Electrophysiology : PACE|January 29, 2015
Electrocardiographic comparison of ventricular premature complexes during exercise test in patients with CPVT and healthy subjectsMiry Blich, Ibrahim Marai, Mahmoud Suleiman, et al.
Circulation. Arrhythmia and Electrophysiology|June 21, 2017
Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2Leonid Maizels, Irit Huber, Gil Arbel, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 14, 2003
Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytesMirit Snir, Izhak Kehat, Amira Gepstein, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Methods in Enzymology|December 31, 2003
Development of cardiomyocytes from human ES cellsIzhak Kehat, Michal Amit, Amira Gepstein, et al.
Heart Rhythm|October 19, 2010
A combined gene and cell therapy approach for restoration of conductionAnat Hofshi, Ilanit Itzhaki, Amira Gepstein, et al.
Circulation. Cardiovascular Genetics|November 9, 2013
Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cellsOren Caspi, Irit Huber, Amira Gepstein, et al.
Tissue Engineering. Part A|August 1, 2009
Transplantation of a tissue-engineered human vascularized cardiac muscleAyelet Lesman, Manhal Habib, Oren Caspi, et al.
Heart Rhythm|August 20, 2013
Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardiaAsaad Khoury, Ibrahim Marai, Mahmoud Suleiman, et al.
American Journal of Cardiovascular Disease|March 18, 2024
The role of early cardiac resynchronization therapy implantation in dilated cardiomyopathy patients with narrow QRS carrying lamin A/C mutationMiry Blich, Wisam Darawsha, Allon Eyal, et al.
The American Journal of Cardiology|April 7, 2012
Importance of ventricular tachycardia storms not terminated by implantable cardioverter defibrillators shocks in patients with CASQ2 associated catecholaminergic polymorphic ventricular tachycardiaIbrahim Marai, Asaad Khoury, Mahmoud Suleiman, et al.
Pacing and Clinical Electrophysiology : PACE|January 29, 2015
Electrocardiographic comparison of ventricular premature complexes during exercise test in patients with CPVT and healthy subjectsMiry Blich, Ibrahim Marai, Mahmoud Suleiman, et al.
Circulation. Arrhythmia and Electrophysiology|June 21, 2017
Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2Leonid Maizels, Irit Huber, Gil Arbel, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 14, 2003
Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytesMirit Snir, Izhak Kehat, Amira Gepstein, et al.
Pageof 13